Proxy Votes Now

Home › Funds › T. Rowe Price › T. Rowe Price Capital Appreciation Equity ETF

T. Rowe Price Capital Appreciation Equity ETF (TCAF) proxy voting record 2025-2026

Fund family: T. Rowe Price · Filed by T. Rowe Price Exchange-Traded Funds, Inc. (CIK 1795351) · SEC series S000079834

Ticker: TCAF (C000241222)

“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 1,020 with, 77 against, 0 abstentions (not counted as with management); 1 items carried no recommendation; 1 split votes are in neither count. Shareholder proposals: 13 FOR, 65 AGAINST, 0 abstained, by the filing’s own vote-source field.

Compared with T. Rowe Price as a whole

The same two figures as T. Rowe Price’s manager page (244,024 ballot items across 112 funds and accounts), counted the same way for this fund.

2025-2026This fundItemsT. Rowe PriceItems
Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters)96.0%99293.7%208,710
Backed environmental and social shareholder proposals at US companies4.0%502.6%3,333

Where this fund voted differently from most T. Rowe Price funds

Each ballot item this fund voted is set against the votes of the other T. Rowe Price funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.

Voted differently from most T. Rowe Price funds on 19 items (1.8% of the 1,074 items where a comparison was possible).

The most lopsided family majorities first, then the largest companies, then shareholder proposals.
CompanyMeetingItemThis fundMost T. Rowe Price fundsMgmtResult
Booking Holdings Inc.2026-06-02Shareholder Non-binding stockholder vote on a proposal to avoid brand damage due to corporate political spending.ForAGAINST — 29 of 29 T. Rowe Price fundsAgainstNot approved, 35.2% support
Apple Inc.2026-02-24The election to Apple's Board of Directors of the eight nominees named in the Proxy Statement: Andrea JungAgainstFOR — 35 of 37 T. Rowe Price fundsAgainstElected, 94.4% support
Meta Platforms, Inc.2026-05-27Shareholder A shareholder proposal regarding disclosure of voting results by share class.ForAGAINST — 40 of 43 T. Rowe Price fundsAgainstNot approved, 20.1% support
Visa Inc.2026-01-27To elect the eleven director nominees named in the proxy statement: William ReadyAgainstFOR — 32 of 34 T. Rowe Price fundsAgainstElected, 79.5% support
KLA Corporation2025-11-05To elect the ten candidates nominated by our Board of Directors to serve as directors for one-year terms, each until his or her successor is duly elected and qualified: Robert CalderoniForAGAINST — 16 of 16 T. Rowe Price fundsForPassed (calculated), 91.5% support
JPMorgan Chase & Co.2026-05-19Shareholder Independent board chairmanForAGAINST — 29 of 31 T. Rowe Price fundsAgainstNot approved, 35.4% support
Thermo Fisher Scientific Inc.2026-05-20An advisory vote to approve named executive officer compensation.AgainstFOR — 36 of 41 T. Rowe Price fundsAgainstNot approved, 31.8% support
NIKE, Inc.2025-09-09Class B director nominees: To elect a Board of Directors for the ensuing year: John Rogers, Jr.WithholdFOR — 10 of 10 T. Rowe Price fundsAgainstPassed (calculated), 64.7% support
Eli Lilly and Company2026-05-04Shareholder Shareholder proposal to adopt a policy and amend the bylaws to require an independent board chair.ForAGAINST — 33 of 40 T. Rowe Price fundsAgainstNot approved, 33.7% support
AMETEK, Inc.2026-05-07Election of Directors for a term of three years: Thomas A. AmatoForAGAINST — 16 of 18 T. Rowe Price fundsForElected, 93.8% support
Otis Worldwide Corporation2026-05-27Shareholder Shareholder proposal regarding reporting on political contributions and expendituresForAGAINST — 11 of 12 T. Rowe Price fundsAgainstNot approved, 45.6% support
Republic Services, Inc.2026-05-07Election of Directors: Katharine B. WeymouthAgainstFOR — 14 of 16 T. Rowe Price fundsAgainstElected, 94.5% support
Vulcan Materials Company2026-05-08Election of Directors: George A. WillisForAGAINST — 4 of 4 T. Rowe Price fundsForElected, 98.5% support
Vulcan Materials Company2026-05-08Election of Directors: Melissa H. AndersonForAGAINST — 4 of 4 T. Rowe Price fundsForElected, 99.2% support
Biogen Inc.2026-06-093 wordings Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Susan K. LangerForAGAINST — 10 of 14 T. Rowe Price fundsForPassed (calculated), 85.3% support
West Pharmaceutical Services, Inc.2026-05-04Shareholder Shareholder proposal regarding an independent Board Chair policy.ForAGAINST — 9 of 13 T. Rowe Price fundsAgainstNot approved, 46.4% support
Alnylam Pharmaceuticals, Inc.2026-05-20To elect the following nominees as Class I directors of Alnylam: Stuart A. ArbuckleAgainstFOR — 10 of 15 T. Rowe Price fundsAgainstElected, 95.8% support
Workday, Inc.2026-06-16Election of Class II Directors: George J. Still, Jr.ForAGAINST — 6 of 8 T. Rowe Price fundsForElected, 97.0% support
Workday, Inc.2026-06-16Election of Class II Directors: Rhonda J. MorrisForAGAINST — 6 of 8 T. Rowe Price fundsForElected, 99.3% support

Download all 19 differences (CSV)

Votes against management by sector

The same votes as “with management” above, by the sector of the company voted on. 96.1% of this fund’s 1,097 such votes could be given a sector; the other 43 (3.9%) are at companies without one and are not in the table.

SectorVotesAgainst managementShare
Technology2613714.2%
Health Care18984.2%
Consumer Discretionary188189.6%
Industrials11721.7%
Utilities11010.9%
Finance9977.1%
Energy4648.7%
Real Estate1400.0%
Miscellaneous1300.0%
Consumer Staples1200.0%
Telecommunications500.0%

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections7800
Audit-related890
Say-on-Pay850
Corporate Governance5022
Compensation302
Other Social Issues2423
Environment or Climate1818
Capital Structure100
Human Rights or Human Capital/workforce88
Shareholder Rights and Defenses43

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
Microsoft CorporationDecember 5, 2025$542M216
Meta Platforms, Inc.May 27, 2026$535M228
Apple Inc.February 24, 2026$488M121
Amazon.com, Inc.May 20, 2026$487M174
Advanced Micro Devices, Inc.May 13, 2026$337M121
NVIDIA CorporationJune 24, 2026$297M164
Alphabet Inc.June 5, 2026$249M2310
Keurig Dr Pepper Inc.June 16, 2026$203M120

Notable votes against management

MeetingCompanyProposalFundMgmt
December 5, 2025Microsoft CorporationEuropean Security Program Censorship Risk Audit Shareholder proposalAgainstFor
December 5, 2025Microsoft CorporationReport on Risks of Censorship in Generative Artificial Intelligence Shareholder proposalAgainstFor
May 27, 2026Meta Platforms, Inc.A shareholder proposal regarding annual vote regarding executive pay. Shareholder proposalForAgainst
May 27, 2026Meta Platforms, Inc.A shareholder proposal regarding dual class capital structure. Shareholder proposalForAgainst
February 24, 2026Apple Inc.A shareholder proposal entitled "China Entanglement Audit" Shareholder proposalAgainstFor
May 20, 2026Amazon.com, Inc.SHAREHOLDER PROPOSAL REQUESTING A REPORT ON CHARITABLE PARTNERSHIPS Shareholder proposalAgainstFor
May 20, 2026Amazon.com, Inc.SHAREHOLDER PROPOSAL REQUESTING ADDITIONAL REPORTING ON IMPACT OF DATA CENTERS ON CLIMATE COMMITMENTS Shareholder proposalAgainstFor
May 13, 2026Advanced Micro Devices, Inc.Stockholder proposal requesting changes to the stockholder right to call a special meeting. Shareholder proposalAgainstFor
June 24, 2026NVIDIA CorporationApproval of a non-binding stockholder proposal requesting the replacement of supermajority voting provisions in our charter and bylaws with a simple majority voting standard. Shareholder proposalForAgainst
June 24, 2026NVIDIA CorporationApproval of a non-binding stockholder proposal requesting a report on faith-based community resource groups. Shareholder proposalAgainstFor
June 5, 2026Alphabet Inc.Shareholder proposal regarding an enhanced disclosure on climate goals Shareholder proposalAgainstFor
June 5, 2026Alphabet Inc.Shareholder proposal regarding a report on water usage and AI development Shareholder proposalAgainstFor

Search this fund’s votes by company

1,101 ballot items at 90 meetings in 2025-2026. Download all votes (CSV)

Recent notable votes

Recent votes against management’s recommendation at large companies.

About this fund’s record

In the 2025-2026 proxy season, T. Rowe Price Capital Appreciation Equity ETF (TCAF) voted at 90 shareholder meetings of 89 companies, on 1,101 ballot items in all. Where management made a recommendation, the fund followed it on 93.0% of the items and voted against it 77 times. Its most frequent area of disagreement was other social issues (23 of its votes against management). It voted FOR 16.7% of the 78 shareholder proposals on which it cast a FOR or AGAINST vote. It voted FOR the board's own proposals more often than T. Rowe Price's funds as a whole (96.0% against 93.7%). It voted differently from most T. Rowe Price funds on 19 items.

About this page

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of T. Rowe Price’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.